Jul 25, 2026 01:10PM
Jul 18, 2026 12:40PM
Jul 11, 2026 12:30PM
Jul 8, 2026 07:30AM
Jul 4, 2026 12:25PM
Jun 27, 2026 02:40PM
Jun 12, 2026 04:39PM Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
Jun 6, 2026 11:20AM
Jun 2, 2026 08:15AM
May 30, 2026 11:55AM
May 23, 2026 12:25PM
May 7, 2026 09:01AM
Apr 25, 2026 12:55PM
Apr 24, 2026 09:25AM CORRECTION: Join Lantern Pharma on April 30 for the First Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers
Apr 24, 2026 09:00AM
Apr 20, 2026 08:05AM
Apr 20, 2026 08:00AM
Apr 14, 2026 08:36AM
Apr 2, 2026 08:45AM
Mar 27, 2026 07:00AM
Mar 21, 2026 01:55PM New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Jan 20, 2026 08:04AM
Jan 12, 2026 09:01AM
Dec 27, 2025 05:00PM
Nov 8, 2025 11:40AM
Nov 7, 2025 09:00AM
Oct 28, 2025 08:50AM
Oct 3, 2025 09:00AM Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Sep 16, 2025 08:27AM
Sep 3, 2025 09:44AM
Aug 19, 2025 08:00AM
Aug 13, 2025 06:08PM
Aug 6, 2025 08:30AM
Aug 4, 2025 08:55AM
Jul 25, 2025 09:00AM Lantern Pharma Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 21, 2025 08:20AM
Jul 15, 2025 09:40AM
May 29, 2025 08:35AM
May 15, 2025 05:03PM
May 12, 2025 09:00AM
Feb 19, 2025 08:02AM
Jan 27, 2025 08:04AM Lantern Pharma (LTRN) Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
Dec 3, 2024 08:05AM
Nov 26, 2024 08:45AM
Nov 7, 2024 04:49PM
Oct 15, 2024 09:07AM
Sep 23, 2024 08:00AM
Jul 10, 2024 08:32AM
Jun 12, 2024 07:31AM Lantern Pharma (LTRN) Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284

435,212 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All